Ginsenoside Rg1 enhances endothelial progenitor cell angiogenic potency and prevents senescence in vitro

Journal of International Medical Research

Volumn 39, Issue 4, 2011, Pages 1306-1318

  Shi, A W ^a,b   Gu, N ^c   Liu, X M ^a   Wang, X ^a   Peng, Y Z ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c NANJING UNIVERSITY OF CHINESE MEDICINE   (China)

Author keywords

Endothelial progenitor cells; Ginsenoside Rg1; Senescence; Telomerase activity

Indexed keywords

GALACTOSIDASE; GINSENOSIDE RG 1; TELOMERASE;

ANGIOGENESIS; ARTICLE; CELL CYCLE; CELL FUNCTION; CELL ISOLATION; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ACTIVITY; ENDOTHELIAL PROGENITOR CELL; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IN VITRO STUDY; SENESCENCE; VOLUNTEER;

EID: 80052192881     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900418     Document Type: Article

References (48)

1. Asahara T, Murohara T, Sullivan A, et al: Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997; 275: 964-967.
2. Xu Q: The impact of progenitor cells in atherosclerosis. Nat Clin Pract Cardiovasc Med 2006; 3: 94-101.
3. Hill JM, Zalos G, Halcox JP, et al: Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003; 348: 593-600.
4. Scheubel RJ, Zorn H, Silber RE, et al: Agedependent depression in circulating endothelial progenitor cells in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol 2003; 42: 2073-2080.
5. Hayflick L, Moorhead PS: The serial cultivation of human diploid cell strains. Exp Cell Res 1961; 25: 585-621.
6. Yang NC, Hu ML: The limitations and validities of senescence associated-β-galactosidase activity as an aging marker for human foreskin fibroblast Hs68 cells. Exp Gerontol 2005; 40: 813-819.
7. Kang MK, Shin KH, Yip FK, et al: Normal human oral keratinocytes demonstrate abnormal DNA end joining activity during premature senescence. Mech Ageing Dev 2005; 126: 475-479.
8. Unterluggauer H, Hampel B, Zwerschke W, et al: Senescence-associated cell death of human endothelial cells: the role of oxidative stress. Exp Gerontol 2003; 38: 1149-1160.
9. Van der Loo B, Fenton MJ, Erusalimsky JD: Cytochemical detection of a senescenceassociated β-galactosidase in endothelial and smooth muscle cells from human and rabbit blood vessels. Exp Cell Res 1998; 241: 309-315.
10. Reincke BS, Rosson GB, Oswald BW, et al: INI1 expression induces cell cycle arrest and markers of senescence in malignant rhabdoid tumor cells. J Cell Physiol 2003; 194: 303-313.
11. Chimenti C, Kajstura J, Torella D, et al: Senescence and death of primitive cells and myocytes lead to premature cardiac aging and heart failure. Circ Res 2003; 93: 604-613.
12. Ball AJ, Levine F: Telomere-independent cellular senescence in human fetal cardiomyocytes. Aging Cell 2005; 4: 21-30.
13. Liao B, Newmark H, Zhou R: Neuroprotective effects of ginseng total saponin and ginsenosides Rb1 and Rg1 on spinal cordneurons in vitro. Exp Neurol 2002; 173: 224-234.
14. Chen XC, Zhu YG, Zhu LA, et al: Ginsenoside Rg1 attenuates dopamine-induced apoptosis in PC12 cells by suppressing oxidative stress. Eur J Pharmacol 2003; 473: 1-7.
15. Chen XC, Chen Y, Zhu YG, et al: Protective effect of ginsenoside Rg1 against MPTP-induced apoptosis in mouse substantia nigra neurons. Acta Pharmacol Sin 2002; 23: 829-834.
16. Cheng Y, Shen LH, Zhang JT: Anti-amnestic and anti-aging effects of ginsenoside Rg1 and Rb1 and its mechanism of action. Acta Pharmacol Sin 2005; 26: 143-149.
17. Lau WS, Chan RY, Guo DA, et al: Ginsenoside Rg1 exerts estrogen-like activities via ligandindependent activation of ERα pathway. J Steroid Biochem Mol Biol 2008; 108: 64-71.
18. Strehlow K, Werner N, Berweiler J, et al: Estrogen increases bone marrow-derived endothelial progenitor cell production and diminishes neointima formation. Circulation 2003; 107: 3059-3065.
19. Lu XZ, Wang JH, Wu X, et al: Ginsenoside Rg1 promotes bone marrow stromal cells proliferation via the activation of the estrogen receptor-mediated signaling pathway. Acta Pharmacol Sin 2008; 29: 1209-1214.
20. Imanishi T, Hano T, Matsuo Y, et al: Oxidized LDL inhibits vascular endothelial growth factor-induced endothelial progenitor cell differentiation. Clin Exp Pharmacol Physiol 2003; 30: 665-670.
21. Bodnar AG, Ouellette M, Frolkis M, et al: Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279: 349-352.
22. Vasa M, Breitschopf K, Zeiher AM, et al: Nitric oxide activates telomerase and delays endothelial cell senescence. Circ Res 2000; 87: 540-542.
23. Imanishi T, Hano T, Nishio I: Angiotension II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens 2005; 23: 97-104.
24. Peichev M, Naiyer AJ, Pereira D, et al: Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000; 95: 952-958.
25. Robert B, St John PL, Hyink DP, et al: Evidence that embryonic kidney cells expressing flk-1 are intrinsic, vasculogenic angioblasts. Am J Physiol 1996; 271: F744-F753.
26. Vasa M, Fichtlscherer S, Aicher A, et al: Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res 2001; 89: E1-E7.
27. Ward MR, Stewart DJ, Kutryk MJ: Endothelial progenitor cell therapy for the treatment of coronary disease, acute MI, and pulmonary arterial hypertension: current perspectives. Catheter Cardiovasc Interv 2007; 70: 983-998.
28. Jujo K, Ii M, Losordo DW: Endothelial progenitor cells in neovascularization of infarcted myocardium. J Mol Cell Cardiol 2008; 45: 530-544.
29. Takeuchi H, Bilchik A, Saha S, et al: C-MET expression level in primary colon cancer: a predictor of tumor invasion and lymph node metastases. Clin Cancer Res 2003; 9: 1480-1488.
30. Kondo T, Hayashi M, Takeshita K, et al: Smoking cessation rapidly increases circulating progenitor cells in peripheral blood in chronic smokers. Arterioscler Thromb Vasc Biol 2004; 24: 1442-1447.
31. Imanishi T, Moriwaki C, Hano T, et al: Endothelial progenitor cell senescence is accelerated in both experimental hypertensive rats and patients with essential hypertension. J Hypertens 2005; 23: 1831-1837.
32. Wang XB, Huang J, Zou JG, et al: Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood. Clin Exp Pharmacol Physiol 2007; 34: 1109-1115.
33. Spyridopoulos I, Haendeler J, Urbich C, et al: Statins enhance migratory capacity by upregulation of the telomere repeat-binding factor TRF2 in endothelial progenitor cells. Circulation 2004; 110: 3136-3142.
34. Levy BI: Beneficial effects of circulating progenitor endothelial cells activated by angiotensin receptor antagonists. Hypertension 2005; 45: 491-492.
35. Attele AS, Wu JA, Yuan CS: Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 1999; 58: 1685-1693.
36. Beloti MM, Bellesini LS, de Oliveira PT, et al: Participation of estrogen receptors in the enhancement of osteoblast differentiation by TAK-778. Mol Cell Biochem 2006; 285: 101-109.
37. Tachikawa E, Kudo K, Hasegawa H, et al: In vitro inhibition of adrenal catecholamine secretion by steroidal metabolites of ginseng saponins. Biochem Pharmacol 2003; 66: 2213-2221.
38. Huang YS, Liu Y, Qu ZW, et al: Effect of ginsenoside Rb1 and Rg1 on lipid peroxidation of rat in vitro. Acta Acad Med Sin 1989; 11: 460-462[in Chinese].
39. Deng HL, Zhang JT: Anti-lipid peroxilative effect of ginsenoside Rb1 and Rg1. Chin Med J (Engl) 1991; 104: 395-398.
40. Wang NY, Lu CJ, Chen XH: Study on effect of ginsenoside Rg1 in promoting myocardiac vascular endothelial cell regeneration through induction on bone marrow stem cell's migration and differentiation in rabbits of myocardial infarction. Zhongguo Zhong Xi Yi Jie He Za Zhi 2005; 25: 916-919[in Chinese, English abstract].
41. Murohara T, Ikeda H, Duan J, et al: Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization. J Clin Invest 2000; 105: 1527-1536.
42. Kocher AA, Schuster MD, Szabolcs MJ, et al: Neovascularization of ischemic myocardium by human bone-marrow derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7: 430-436.
43. Edelberg JM, Tang L, Hattori K, et al: Young adult bone marrow-derived endothelial precursor cells restore aging-impaired cardiac angiogenic function. Circ Res 2002; 90: E89-E93.
44. Mouton RE, Venable ME: Ceramide induces expression of the senescence histochemical marker, beta-galactosidase, in human fibroblasts. Mech Ageing Dev 2000; 113: 169-181.
45. Stockschläder MA, Schuening FG, Graham TC, et al: Transplantation of retrovirus-transduced canine keratinocytes expressing the betagalactosidase gene. Gene Ther 1994; 1: 317-322.
46. Dimri GP, Lee X, Basile G, et al: A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A 1995: 92: 9363-9367.
47. Minamino T, Mitsialis SA, Kourembanas S: Hypoxia extends the life span of vascular smooth muscle cells through telomerase activation. Mol Cell Biol 2001; 21: 3336-3342.
48. Seimiya H, Tanji M, Oh-hara T, et al: Hypoxia up-regulates telomerase activity via mitogenactivated protein kinase signaling in human solid tumor cells. Biochem Biophys Res Commun 1999; 260: 365-370.